divalproex


Also found in: Medical, Encyclopedia, Wikipedia.

di·val·pro·ex

 (dī-văl′prō-ĕks′)
n.
A combination of the drugs valproate and valproic acid, used primarily to treat mania in bipolar disorder and seizures.

[di- + valpro- (from valproate valproic acid) + -ex, arbitrary suff.]
References in periodicals archive ?
com announces addition of 3 divalproex sodium market research reports covering current status and 2020 forecasts for global markets as well as individually for China and India along with analysis of major players.
Divalproex sodium, lamotrigine, and naltrexone have much less supporting evidence.
Recommendations for pharmacological treatment of acute bipolar II depression[1] First line Quetiapine * Second line Lithium Lamotrigine Divalproex * Lithium or divalproex + antidepressants Lithium + divalproex Atypical antipsychotics + antidepressants Third line Antidepressant monotherapy (particularly for those with infrequent hypomanias), switch to alternate antidepressant Ziprasidone * Not recommended Risk-benefit ratio for antidepressant use in BD II is still an unresolved issue Switch rates with antidepressants are lower in patients with BD II compared with those with BD I * New Table 3.
Products include valproate sodium (Depacon), divalproex sodium (Depakote, Depakote CP, and Depakote ER), valproic acid (Depakene and Stavzor), and generic versions.
Valproate products include valproate sodium (Depacon), divalproex sodium (Depakote, Depakote CP, and Depakote ER), valproic acid (Depakene and Stavzor), and generic versions of these products.
Divalproex sodium (Depakote), sodium valproate (Depacon), and topiramate (Topamax).
Patients may take the therapy as an adjunct to the standard treatments lithium or divalproex, London-based AstraZeneca said.
He was on prednisone, temazepam, promethazine and divalproex.
The researchers found that more than three-quarters of at-risk kids showed improvement in their mood or behavioral disorders after receiving a drug called divalproex.
SEROQUEL is indicated in adults for the treatment of (1) acute depressive episodes in bipolar disorder; (2) acute manic episodes in bipolar I disorder, as either monotherapy or adjunct therapy to lithium or divalproex; (3) maintenance treatment of bipolar I disorder as an adjunct to lithium or divalproex, and (4) schizophrenia.
The Global Divalproex Sodium Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Divalproex Sodium industry.